About the event
This event highlights the whole value chain of novel drugs – all the way from early discovery to later stage development – providing a unique opportunity for research leaders and product developers to come together and engage with cutting-edge ideas and best practices across the field of drug discovery, formulation & delivery.
LifeArc presentations
Day 1
Manuela Cerina, Scientific Director – Neurodegeneration:
Biomarkers: Challenges in translational neurodegeneration research
James Connel, Scientific Director, Translational Matrix Group:
Panel discussion – Translational studies to support better drug design
Sarah Jolly, Principal Scientist, Translational Matrix Group:
Panel discussion – Bridging The Gap Between Pharma & Academia To Accelerate Neurodegenerative Disease Research
Day 2
Manuela Cerina, Scientific Director – Neurodegeneration:
Panel Chair – Biomarkers In Neurodegenerative Diseases: From Detection To Progression – Are Blood -Based Biomarkers Enough?
James Connel, Scientific Director, Translational Matrix Group:
Panel discussion –Biomarkers In Neurodegenerative Diseases: From Detection To Progression – Are Blood -Based Biomarkers Enough?
Zhi Yao, Principal Scientist, Translational Matrix Group:
Presentation Exploring neuroinflammation targets for Amyotrophic Lateral Sclerosis (ALS)
